Selling, General, and Administrative Costs: Walgreens Boots Alliance, Inc. vs Supernus Pharmaceuticals, Inc.

SG&A Expenses: Walgreens vs. Supernus - A Decade of Change

__timestampSupernus Pharmaceuticals, Inc.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 20147247100017992000000
Thursday, January 1, 20158920400022400000000
Friday, January 1, 201610601000023910000000
Sunday, January 1, 201713790500023813000000
Monday, January 1, 201815988800024694000000
Tuesday, January 1, 201915842500023557000000
Wednesday, January 1, 202020067700025436000000
Friday, January 1, 202130475900024586000000
Saturday, January 1, 202237722100027295000000
Sunday, January 1, 202333636100034205000000
Monday, January 1, 202428113000000
Loading chart...

Infusing magic into the data realm

A Tale of Two Companies: SG&A Expenses Over Time

In the world of pharmaceuticals and retail, managing costs is crucial for profitability. This chart compares the Selling, General, and Administrative (SG&A) expenses of Walgreens Boots Alliance, Inc. and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Walgreens, a retail giant, consistently reported SG&A expenses over $17 billion annually, peaking at $28 billion in 2024. In contrast, Supernus, a smaller pharmaceutical company, saw its expenses grow from $72 million in 2014 to $377 million in 2022, marking a 422% increase. This stark difference highlights the scale and operational complexities of these companies. While Walgreens' expenses reflect its vast retail operations, Supernus' growth in expenses indicates its expanding footprint in the pharmaceutical industry. Notably, data for Supernus in 2024 is missing, suggesting a need for further investigation into its financial trajectory.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025